{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:08:02Z","timestamp":1783080482386,"version":"3.54.6"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T00:00:00Z","timestamp":1513209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00395-017-0664-8","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T13:07:15Z","timestamp":1513256835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Pre- and postconditioning the heart with hydrogen sulfide (H2S) against ischemia\/reperfusion injury in vivo: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2897-6630","authenticated-orcid":false,"given":"Qutuba G.","family":"Karwi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin S.","family":"Bice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary F.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,14]]},"reference":[{"key":"664_CR1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/bph.12811","volume":"172","author":"I Andreadou","year":"2015","unstructured":"Andreadou I, Iliodromitis EK, Rassaf T, Schulz R, Papapetropoulos A, Ferdinandy P (2015) The role of gasotransmitters NO, H2S and CO in myocardial ischaemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. Br J Pharmacol 172:1587\u20131606. \n                        https:\/\/doi.org\/10.1111\/bph.12811","journal-title":"Br J Pharmacol"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00395-016-0558-1","volume":"111","author":"RM Bell","year":"2016","unstructured":"Bell RM, Botker HE, Carr RD, Davidson SM, Downey JM, Dutka DP, Heusch G, Ibanez B, Macallister R, Stoppe C, Ovize M, Redington A, Walker JM, Yellon DM (2016) 9th hatter biannual meeting: position document on ischaemia\/reperfusion injury, conditioning and the ten commandments of cardioprotection. Basic Res Cardiol 111:41. \n                        https:\/\/doi.org\/10.1007\/s00395-016-0558-1","journal-title":"Basic Res Cardiol"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/cvr\/cvv129","volume":"106","author":"SI Bibli","year":"2015","unstructured":"Bibli SI, Andreadou I, Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, Brouckaert P, Coletta C, Szabo C, Kremastinos DT, Iliodromitis EK, Papapetropoulos A (2015) Cardioprotection by H2S engages a cGMP-dependent protein kinase G\/phospholamban pathway. Cardiovasc Res 106:432\u2013442. \n                        https:\/\/doi.org\/10.1093\/cvr\/cvv129","journal-title":"Cardiovasc Res"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00395-016-0540-y","volume":"111","author":"JS Bice","year":"2016","unstructured":"Bice JS, Jones BR, Chamberlain GR, Baxter GF (2016) Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies. Basic Res Cardiol 111:23. \n                        https:\/\/doi.org\/10.1007\/s00395-016-0540-y","journal-title":"Basic Res Cardiol"},{"key":"664_CR5","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/bph.12869","volume":"172","author":"EM Bos","year":"2015","unstructured":"Bos EM, van Goor H, Joles JA, Whiteman M, Leuvenink HG (2015) Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. Br J Pharmacol 172:1479\u20131493. \n                        https:\/\/doi.org\/10.1111\/bph.12869","journal-title":"Br J Pharmacol"},{"key":"664_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/cvr\/cvw219","volume":"113","author":"DI Bromage","year":"2017","unstructured":"Bromage DI, Pickard JM, Rossello X, Ziff OJ, Burke N, Yellon DM, Davidson SM (2017) Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia\u2013reperfusion injury: a systematic review and meta-analysis. Cardiovasc Res 113:288\u2013297. \n                        https:\/\/doi.org\/10.1093\/cvr\/cvw219","journal-title":"Cardiovasc Res"},{"key":"664_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/heartjnl-2015-307855","volume":"102","author":"H Bulluck","year":"2016","unstructured":"Bulluck H, Yellon DM, Hausenloy DJ (2016) Reducing myocardial infarct size: challenges and future opportunities. Heart 102:341\u2013348. \n                        https:\/\/doi.org\/10.1136\/heartjnl-2015-307855","journal-title":"Heart"},{"key":"664_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00395-015-0527-0","volume":"111","author":"HA Cabrera-Fuentes","year":"2016","unstructured":"Cabrera-Fuentes HA, Alba-Alba C, Aragones J, Bernhagen J, Boisvert WA, Botker HE, Cesarman-Maus G, Fleming I, Garcia-Dorado D, Lecour S, Liehn E, Marber MS, Marina N, Mayr M, Perez-Mendez O, Miura T, Ruiz-Meana M, Salinas-Estefanon EM, Ong SB, Schnittler HJ, Sanchez-Vega JT, Sumoza-Toledo A, Vogel CW, Yarullina D, Yellon DM, Preissner KT, Hausenloy DJ (2016) Meeting report from the 2nd international symposium on new frontiers in cardiovascular research. protecting the cardiovascular system from ischemia: between bench and bedside. Basic Res Cardiol 111:7. \n                        https:\/\/doi.org\/10.1007\/s00395-015-0527-0","journal-title":"Basic Res Cardiol"},{"key":"664_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","volume":"105","author":"JW Calvert","year":"2009","unstructured":"Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ (2009) Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105:365\u2013374. \n                        https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.199919","journal-title":"Circ Res"},{"key":"664_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1124\/jpet.116.235119","volume":"106","author":"A Chatzianastasiou","year":"2016","unstructured":"Chatzianastasiou A, Bibli SI, Andreadou I, Efentakis P, Kaludercic N, Wood ME, Whiteman M, Di Lisa F, Daiber A, Manolopoulos VG, Szabo C, Papapetropoulos A (2016) Cardioprotection by H2S donors: nitric oxide-dependent and -independent mechanisms. J Pharmacol Exp Ther 106:432\u2013442. \n                        https:\/\/doi.org\/10.1124\/jpet.116.235119","journal-title":"J Pharmacol Exp Ther"},{"key":"664_CR11","doi-asserted-by":"publisher","first-page":"30643-30456","DOI":"10.1038\/srep30643","volume":"6","author":"GB Chen","year":"2016","unstructured":"Chen GB, Yang L, Zhong LT, Kutty S, Wang YG, Cui K, Xiu JC, Cao SP, Huang QB, Liao WJ, Liao YL, Wu JF, Zhang WZ, Bin JP (2016) Delivery of hydrogen sulfide by ultrasound targeted microbubble destruction attenuates myocardial ischemia\u2013reperfusion injury. Sci Rep 6:30643-30456. \n                        https:\/\/doi.org\/10.1038\/srep30643","journal-title":"Sci Rep"},{"key":"664_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00395-015-0500-y","volume":"110","author":"A Das","year":"2015","unstructured":"Das A, Samidurai A, Hoke NN, Kukreja RC, Salloum FN (2015) Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-I alpha. Basic Res Cardiol 110:42\u201354. \n                        https:\/\/doi.org\/10.1007\/s00395-015-0500-y","journal-title":"Basic Res Cardiol"},{"key":"664_CR13","doi-asserted-by":"publisher","first-page":"e003531","DOI":"10.1161\/jaha.116.003531","volume":"5","author":"E Donnarumma","year":"2016","unstructured":"Donnarumma E, Ali MJ, Rushing AM, Scarborough AL, Bradley JM, Organ CL, Islam KN, Polhemus DJ, Evangelista S, Cirino G, Jenkins JS, Patel RAG, Lefer DJ, Goodchild TT (2016) Zofenopril protects against myocardial ischemia\u2013reperfusion injury by increasing nitric oxide and hydrogen sulfide bioavailability. J Am Heart Assoc 5:e003531\u2013e003549. \n                        https:\/\/doi.org\/10.1161\/jaha.116.003531","journal-title":"J Am Heart Assoc"},{"key":"664_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/cphy.c160023","volume":"7","author":"E Donnarumma","year":"2017","unstructured":"Donnarumma E, Trivedi RK, Lefer DJ (2017) Protective actions of H2S in acute myocardial infarction and heart failure. Compr Physiol 7:583\u2013602. \n                        https:\/\/doi.org\/10.1002\/cphy.c160023","journal-title":"Compr Physiol"},{"key":"664_CR15","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1161\/RES.0000000000000038","volume":"115","author":"D Durrant","year":"2014","unstructured":"Durrant D, Mauro AG, Raleigh JV, Das A, He J, Nguyen K, Toldo S, Abbate A, Salloum FN (2014) MAVS mediates protection against myocardial ischemic injury with hydrogen sulfide. Circ Res 115:E87. \n                        https:\/\/doi.org\/10.1161\/RES.0000000000000038","journal-title":"Circ Res"},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/eurheartj\/ehv463","volume":"36","author":"I Eitel","year":"2015","unstructured":"Eitel I, Stiermaier T, Rommel KP, Fuernau G, Sandri M, Mangner N, Linke A, Erbs S, Lurz P, Boudriot E, Mende M, Desch S, Schuler G, Thiele H (2015) Cardioprotection by combined intrahospital remote ischaemic preconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. Eur Heart J 36:3049\u20133057. \n                        https:\/\/doi.org\/10.1093\/eurheartj\/ehv463","journal-title":"Eur Heart J"},{"key":"664_CR17","doi-asserted-by":"publisher","first-page":"15560","DOI":"10.1073\/pnas.0705891104","volume":"104","author":"JW Elrod","year":"2007","unstructured":"Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ (2007) Hydrogen sulfide attenuates myocardial ischemia\u2013reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104:15560\u201315565. \n                        https:\/\/doi.org\/10.1073\/pnas.0705891104","journal-title":"Proc Natl Acad Sci USA"},{"key":"664_CR18","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1124\/pr.113.008300","volume":"66","author":"P Ferdinandy","year":"2014","unstructured":"Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R (2014) Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 66:1142\u20131174. \n                        https:\/\/doi.org\/10.1124\/pr.113.008300","journal-title":"Pharmacol Rev"},{"key":"664_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijcard.2010.07.012","volume":"152","author":"Y Gao","year":"2011","unstructured":"Gao Y, Yao XY, Zhang YN, Li WM, Kang K, Sun L, Sun XY (2011) The protective role of hydrogen sulfide in myocardial ischemia\u2013reperfusion-induced injury in diabetic rats. Int J Cardiol 152:177\u2013183. \n                        https:\/\/doi.org\/10.1016\/j.ijcard.2010.07.012","journal-title":"Int J Cardiol"},{"key":"664_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00395-016-0588-8","volume":"111","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy DJ, Barrabes JA, Botker HE, Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P, Carbrera-Fuentes HA, Heusch G, Ibanez B, Iliodromitis EK, Inserte J, Jennings R, Kalia N, Kharbanda R, Lecour S, Marber M, Miura T, Ovize M, Perez-Pinzon MA, Piper HM, Przyklenk K, Schmidt MR, Redington A, Ruiz-Meana M, Vilahur G, Vinten-Johansen J, Yellon DM, Garcia-Dorado D (2016) Ischaemic conditioning and targeting reperfusion injury: a 30\u00a0year voyage of discovery. Basic Res Cardiol 111:70\u201394. \n                        https:\/\/doi.org\/10.1007\/s00395-016-0588-8","journal-title":"Basic Res Cardiol"},{"key":"664_CR21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/eurheartj\/ehw145","volume":"38","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B, Kloner RA, Ovize M, Yellon DM, Garcia-Dorado D (2017) Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J 38:935\u2013941. \n                        https:\/\/doi.org\/10.1093\/eurheartj\/ehw145","journal-title":"Eur Heart J"},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cvr\/cvx049","volume":"113","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy DJ, Garcia-Dorado D, B\u00f8tker HE, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JPG, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P (2017) Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Cardiovasc Res 113:564\u2013585. \n                        https:\/\/doi.org\/10.1093\/cvr\/cvx049","journal-title":"Cardiovasc Res"},{"key":"664_CR23","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","volume":"120","author":"G Heusch","year":"2017","unstructured":"Heusch G (2017) Critical issues for the translation of cardioprotection. Circ Res 120:1477\u20131486. \n                        https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310820","journal-title":"Circ Res"},{"key":"664_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","volume":"116","author":"G Heusch","year":"2015","unstructured":"Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116:674\u2013699. \n                        https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305348","journal-title":"Circ Res"},{"key":"664_CR25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/eurheartj\/ehw224","volume":"38","author":"G Heusch","year":"2017","unstructured":"Heusch G, Gersh BJ (2017) The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 38:774\u2013784. \n                        https:\/\/doi.org\/10.1093\/eurheartj\/ehw224","journal-title":"Eur Heart J"},{"key":"664_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2307\/4615733","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6:65\u201370. \n                        https:\/\/doi.org\/10.2307\/4615733","journal-title":"Scand J Stat"},{"key":"664_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/ilar\/ilu042","volume":"55","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, IntHout J, Ritskes-Hoitinga M, Rovers MM (2014) Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare. ILAR J 55:418\u2013426. \n                        https:\/\/doi.org\/10.1093\/ilar\/ilu042","journal-title":"ILAR J"},{"key":"664_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3892\/etm.2012.733","volume":"4","author":"YE Huang","year":"2012","unstructured":"Huang YE, Tang ZH, Xie W, Shen XT, Liu MH, Peng XP, Zhao ZZ, Nie DB, Liu LS, Jiang ZS (2012) Endogenous hydrogen sulfide mediates the cardioprotection induced by ischemic postconditioning in the early reperfusion phase. Exp Ther Med 4:1117\u20131123. \n                        https:\/\/doi.org\/10.3892\/etm.2012.733","journal-title":"Exp Ther Med"},{"key":"664_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.niox.2013.04.008","volume":"32","author":"HF Jin","year":"2013","unstructured":"Jin HF, Wang Y, Wang XB, Sun Y, Tang CS, Du JB (2013) Sulfur dioxide preconditioning increases antioxidative capacity in rat with myocardial ischemia reperfusion (I\/R) injury. Nitric Oxide 32:56\u201361. \n                        https:\/\/doi.org\/10.1016\/j.niox.2013.04.008","journal-title":"Nitric Oxide"},{"key":"664_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000455816","volume":"41","author":"B Kang","year":"2017","unstructured":"Kang B, Li W, Xi W, Yi Y, Ciren Y, Shen H, Zhang Y, Jiang H, Xiao J, Wang Z (2017) Hydrogen sulfide protects cardiomyocytes against apoptosis in ischemia\/reperfusion through mir-1-regulated histone deacetylase 4 pathway. Cell Physiol Biochem 41:10\u201321. \n                        https:\/\/doi.org\/10.1159\/000455816","journal-title":"Cell Physiol Biochem"},{"key":"664_CR31","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1021\/jacs.6b01373","volume":"138","author":"JM Kang","year":"2016","unstructured":"Kang JM, Li Z, Organ CL, Park CM, Yang CT, Pacheco A, Wang DF, Lefer DJ, Xian M (2016) pH-controlled hydrogen sulfide release for myocardial ischemia\u2013reperfusion injury. J Am Chem Soc 138:6336\u20136339. \n                        https:\/\/doi.org\/10.1021\/jacs.6b01373","journal-title":"J Am Chem Soc"},{"key":"664_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bph.13688","volume":"174","author":"QG Karwi","year":"2017","unstructured":"Karwi QG, Bornbaum J, Boengler K, Torregrossa R, Whiteman M, Wood ME, Schulz R, Baxter GF (2017) AP39, a mitochondria-targeting hydrogen sulfide (H2S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling. Br J Pharmacol 174:287\u2013301. \n                        https:\/\/doi.org\/10.1111\/bph.13688","journal-title":"Br J Pharmacol"},{"key":"664_CR33","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.phrs.2016.06.028","volume":"111","author":"QG Karwi","year":"2016","unstructured":"Karwi QG, Whiteman M, Wood ME, Torregrossa R, Baxter GF (2016) Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137. Pharmacol Res 111:442\u2013451. \n                        https:\/\/doi.org\/10.1016\/j.phrs.2016.06.028","journal-title":"Pharmacol Res"},{"key":"664_CR34","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","volume":"160","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, Group NCRRGW (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160:1577\u20131579. \n                        https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00872.x","journal-title":"Br J Pharmacol"},{"key":"664_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13618-014-0020-0","volume":"4","author":"JP Lambert","year":"2014","unstructured":"Lambert JP, Nicholson CK, Amin H, Amin S, Calvert JW (2014) Hydrogen sulfide provides cardioprotection against myocardial\/ischemia reperfusion injury in the diabetic state through the activation of the RISK pathway. Med Gas Res 4:20\u201331. \n                        https:\/\/doi.org\/10.1186\/s13618-014-0020-0","journal-title":"Med Gas Res"},{"key":"664_CR36","first-page":"7740","volume":"8","author":"CY Li","year":"2015","unstructured":"Li CY, Hu M, Wang Y, Lu H, Deng J, Yan XH (2015) Hydrogen sulfide preconditioning protects against myocardial ischemia\/reperfusion injury in rats through inhibition of endo\/sarcoplasmic reticulum stress. Int J Clin Exp Pathol 8:7740\u20137751","journal-title":"Int J Clin Exp Pathol"},{"key":"664_CR37","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1111\/j.1476-5381.2011.01691.x","volume":"165","author":"WY Lim","year":"2012","unstructured":"Lim WY, Messow CM, Berry C (2012) Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis. Br J Pharmacol 165:2034\u20132043. \n                        https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01691.x","journal-title":"Br J Pharmacol"},{"key":"664_CR38","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1021\/acs.jmedchem.5b01223","volume":"59","author":"N Lougiakis","year":"2016","unstructured":"Lougiakis N, Papapetropoulos A, Gikas E, Toumpas S, Efentakis P, Wedmann R, Zoga A, Zhou ZM, Iliodromitis EK, Skaltsounis AL, Filipovic MR, Pouli N, Marakos P, Andreadou I (2016) Synthesis and pharmacological evaluation of novel adenine-hydrogen sulfide slow release hybrids designed as multitarget cardioprotective agents. J Med Chem 59:1776\u20131790. \n                        https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01223","journal-title":"J Med Chem"},{"key":"664_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.phrs.2016.08.023","volume":"113","author":"K Modis","year":"2016","unstructured":"Modis K, Ju Y, Ahmad A, Untereiner AA, Altaany Z, Wu L, Szabo C, Wang R (2016) S-sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics. Pharmacol Res 113:116\u2013124. \n                        https:\/\/doi.org\/10.1016\/j.phrs.2016.08.023","journal-title":"Pharmacol Res"},{"key":"664_CR40","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006\u20131012. \n                        https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005","journal-title":"J Clin Epidemiol"},{"key":"664_CR41","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","volume":"118","author":"E Murphy","year":"2016","unstructured":"Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GW 2nd, Kitsis RN, Otsu K, Ping P, Rizzuto R, Sack MN, Wallace D, Youle RJ, American Heart Association Council on Basic Cardiovascular Sciences CoCC, Council on Functional G, Translational B (2016) Mitochondrial function, biology, and role in disease: a scientific statement from the American Heart Association. Circ Res 118:1960\u20131991. \n                        https:\/\/doi.org\/10.1161\/RES.0000000000000104","journal-title":"Circ Res"},{"key":"664_CR42","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cardiores.2007.03.025","volume":"75","author":"E Murphy","year":"2007","unstructured":"Murphy E, Steenbergen C (2007) Gender-based differences in mechanisms of protection in myocardial ischemia\u2013reperfusion injury. Cardiovasc Res 75:478\u2013486. \n                        https:\/\/doi.org\/10.1016\/j.cardiores.2007.03.025","journal-title":"Cardiovasc Res"},{"key":"664_CR43","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","volume":"74","author":"CE Murry","year":"1986","unstructured":"Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124\u20131136. \n                        https:\/\/doi.org\/10.1161\/01.CIR.74.5.1124","journal-title":"Circulation"},{"key":"664_CR44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/9780470712184.ch5","volume-title":"Cochrane handbook for systematic reviews of interventions: Cochrane book series","author":"D O\u2019Connor","year":"2008","unstructured":"O\u2019Connor D, Green S, Higgins JP (2008) Defining the review question and developing criteria for including studies. In: Higgins JP, Green S (eds) Cochrane handbook for systematic reviews of interventions: Cochrane book series. Wiley, Chichester, UK, pp 81\u201394"},{"key":"664_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/FJC.0b013e3181b2b72b","volume":"54","author":"RM Osipov","year":"2009","unstructured":"Osipov RM, Robich MP, Feng J, Liu Y, Clements RT, Glazer HP, Sodha NR, Szabo C, Bianchi C, Sellke FW (2009) Effect of hydrogen sulfide in a porcine model of myocardial ischemia\u2013reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J Cardiovasc Pharmacol 54:287\u2013297. \n                        https:\/\/doi.org\/10.1097\/FJC.0b013e3181b2b72b","journal-title":"J Cardiovasc Pharmacol"},{"key":"664_CR46","doi-asserted-by":"publisher","first-page":"H1215","DOI":"10.1152\/ajpheart.00796.2012","volume":"304","author":"BF Peake","year":"2013","unstructured":"Peake BF, Nicholson CK, Lambert JP, Hood RL, Amin H, Amin S, Calvert JW (2013) Hydrogen sulfide preconditions the db\/db diabetic mouse heart against ischemia\u2013reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. Am J Physiol Heart Circ Physiol 304:H1215\u2013H1224. \n                        https:\/\/doi.org\/10.1152\/ajpheart.00796.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"664_CR47","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.jacc.2014.08.008","volume":"64","author":"SJ Pocock","year":"2014","unstructured":"Pocock SJ, Gersh BJ (2014) Do current clinical trials meet society\u2019s needs? J Am Coll Cardiol 64:1615\u20131628. \n                        https:\/\/doi.org\/10.1016\/j.jacc.2014.08.008","journal-title":"J Am Coll Cardiol"},{"key":"664_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/1755-5922.12128","volume":"33","author":"DJ Polhemus","year":"2015","unstructured":"Polhemus DJ, Li Z, Pattillo CB, Gojon G Sr, Gojon G Jr, Giordano T, Krum H (2015) A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients. Cardiovasc Ther 33:216\u2013226. \n                        https:\/\/doi.org\/10.1111\/1755-5922.12128","journal-title":"Cardiovasc Ther"},{"key":"664_CR49","doi-asserted-by":"publisher","first-page":"H2410","DOI":"10.1152\/ajpheart.00044.2012","volume":"302","author":"BL Predmore","year":"2012","unstructured":"Predmore BL, Kondo K, Bhushan S, Zlatopolsky MA, King AL, Aragon JP, Grinsfelder DB, Condit ME, Lefer DJ (2012) The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am J Physiol Heart Circ Physiol 302:H2410\u2013H2418. \n                        https:\/\/doi.org\/10.1152\/ajpheart.00044.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"664_CR50","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijcard.2016.06.131","volume":"220","author":"X Rossello","year":"2016","unstructured":"Rossello X, Yellon DM (2016) A critical review on the translational journey of cardioprotective therapies! Int J Cardiol 220:176\u2013184. \n                        https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.131","journal-title":"Int J Cardiol"},{"key":"664_CR51","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1161\/circulationaha.108.843979","volume":"120","author":"FN Salloum","year":"2009","unstructured":"Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC (2009) Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia\/reperfusion through protein-kinase G-dependent generation of hydrogen sulfide. Circ 120:S31\u2013S36. \n                        https:\/\/doi.org\/10.1161\/circulationaha.108.843979","journal-title":"Circ"},{"key":"664_CR52","doi-asserted-by":"publisher","first-page":"H1347","DOI":"10.1152\/ajpheart.00544.2011","volume":"302","author":"FN Salloum","year":"2012","unstructured":"Salloum FN, Das A, Samidurai A, Hoke NN, Chau VQ, Ockaili RA, Stasch JP, Kukreja RC (2012) Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia\/reperfusion injury: role of hydrogen sulfide. Am J Physiol Heart Circ Physiol 302:H1347\u2013H1354. \n                        https:\/\/doi.org\/10.1152\/ajpheart.00544.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"664_CR53","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/1535370214558024","volume":"240","author":"FN Salloum","year":"2015","unstructured":"Salloum FN, Sturz GR, Yin C, Rehman S, Hoke NN, Kukreja RC, Xi L (2015) Beetroot juice reduces infarct size and improves cardiac function following ischemia\u2013reperfusion injury: possible involvement of endogenous H2S. Exp Biol Med 240:669\u2013681. \n                        https:\/\/doi.org\/10.1177\/1535370214558024","journal-title":"Exp Biol Med"},{"key":"664_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/SHK.0b013e318180ff89","volume":"31","author":"A Sivarajah","year":"2009","unstructured":"Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C (2009) Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I\/R. Shock 31:267\u2013274. \n                        https:\/\/doi.org\/10.1097\/SHK.0b013e318180ff89","journal-title":"Shock"},{"key":"664_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.shk.0000225722.56681.64","volume":"27","author":"A Sivarajah","year":"2006","unstructured":"Sivarajah A, McDonald M, Thiemermann C (2006) Endogenous hydrogen sulfide contributes to the cardioprotective effects of pre-conditioning with endotoxin, but not ischemia, in the rat. Acta Pharmacol Sin 27:161\u2013162. \n                        https:\/\/doi.org\/10.1097\/01.shk.0000225722.56681.64","journal-title":"Acta Pharmacol Sin"},{"key":"664_CR56","doi-asserted-by":"publisher","first-page":"e63291","DOI":"10.1371\/journal.pone.0063291","volume":"8","author":"PM Snijder","year":"2013","unstructured":"Snijder PM, de Boer RA, Bos EM, van den Born JC, Ruifrok WPT, Vreeswijk-Baudoin I, van Dijk M, Hillebrands JL, Leuvenink HGD, van Goor H (2013) Gaseous hydrogen sulfide protects against myocardial ischemia\u2013reperfusion injury in mice partially independent from hypometabolism. PLoS One 8:e63291\u2013e63302. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0063291","journal-title":"PLoS One"},{"key":"664_CR57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.phrs.2016.09.006","volume":"113","author":"L Testai","year":"2016","unstructured":"Testai L, Marino A, Piano I, Brancaleone V, Tomita K, Di Cesare Mannelli L, Martelli A, Citi V, Breschi MC, Levi R, Gargini C, Bucci M, Cirino G, Ghelardini C, Calderone V (2016) The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia\/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress. Pharmacol Res 113:290\u2013299. \n                        https:\/\/doi.org\/10.1016\/j.phrs.2016.09.006","journal-title":"Pharmacol Res"},{"key":"664_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/circgenetics.113.000381","volume":"7","author":"S Toldo","year":"2014","unstructured":"Toldo S, Das A, Mezzaroma E, Chau VQ, Marchetti C, Durrant D, Samidurai A, Van Tassell BW, Yin C, Ockaili RA, Vigneshwar N, Mukhopadhyay ND, Kukreja RC, Abbate A, Salloum FN (2014) Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice. Circ Cardiovasc Genet 7:311\u2013320. \n                        https:\/\/doi.org\/10.1161\/circgenetics.113.000381","journal-title":"Circ Cardiovasc Genet"},{"key":"664_CR59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jneumeth.2013.09.010","volume":"221","author":"HM Vesterinen","year":"2014","unstructured":"Vesterinen HM, Sena ES, Egan KJ, Hirst TC, Churolov L, Currie GL, Antonic A, Howells DW, Macleod MR (2014) Meta-analysis of data from animal studies: a practical guide. J Neurosci Methods 221:92\u2013102. \n                        https:\/\/doi.org\/10.1016\/j.jneumeth.2013.09.010","journal-title":"J Neurosci Methods"},{"key":"664_CR60","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrd4433","volume":"14","author":"JL Wallace","year":"2015","unstructured":"Wallace JL, Wang R (2015) Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat Rev Drug Discov 14:329\u2013345. \n                        https:\/\/doi.org\/10.1038\/nrd4433","journal-title":"Nat Rev Drug Discov"},{"key":"664_CR61","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/0006-2952(89)90288-8","volume":"38","author":"MW Warenycia","year":"1989","unstructured":"Warenycia MW, Goodwin LR, Benishin CG, Reiffenstein RJ, Francom DM, Taylor JD, Dieken FP (1989) Acute hydrogen sulfide poisoning. Demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels. Biochem Pharmacol 38:973\u2013981. \n                        https:\/\/doi.org\/10.1016\/0006-2952(89)90288-8","journal-title":"Biochem Pharmacol"},{"key":"664_CR62","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1038\/s41598-017-05457-z","volume":"7","author":"D Wu","year":"2017","unstructured":"Wu D, Li M, Tian W, Wang S, Cui L, Li H, Wang H, Ji A, Li Y (2017) Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR\/ERK\/MMP-2 and PTEN\/AKT signaling pathways. Sci Rep 7:5134\u20135148. \n                        https:\/\/doi.org\/10.1038\/s41598-017-05457-z","journal-title":"Sci Rep"},{"key":"664_CR63","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.bbrc.2015.02.017","volume":"458","author":"H Xie","year":"2015","unstructured":"Xie H, Xu Q, Jia J, Ao G, Sun Y, Hu L, Alkayed NJ, Wang C, Cheng J (2015) Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux. Biochem Biophys Res Commun 458:632\u2013638. \n                        https:\/\/doi.org\/10.1016\/j.bbrc.2015.02.017","journal-title":"Biochem Biophys Res Commun"},{"key":"664_CR64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10557-013-6474-9","volume":"27","author":"XM Yang","year":"2013","unstructured":"Yang XM, Cui L, Alhammouri A, Downey JM, Cohen MV (2013) Triple therapy greatly increases myocardial salvage during ischemia\/reperfusion in the in situ rat heart. Cardiovasc Drugs Ther 27:403\u2013412. \n                        https:\/\/doi.org\/10.1007\/s10557-013-6474-9","journal-title":"Cardiovasc Drugs Ther"},{"key":"664_CR65","doi-asserted-by":"publisher","first-page":"H1310","DOI":"10.1152\/ajpheart.00339.2009","volume":"298","author":"LL Yao","year":"2010","unstructured":"Yao LL, Huang XW, Wang YG, Cao YX, Zhang CC, Zhu YC (2010) Hydrogen sulfide protects cardiomyocytes from hypoxia\/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. Am J Physiol Heart Circ Physiol 298:H1310\u2013H1319. \n                        https:\/\/doi.org\/10.1152\/ajpheart.00339.2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"664_CR66","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1620\/tjem.226.275","volume":"226","author":"X Yao","year":"2012","unstructured":"Yao X, Tan G, He C, Gao Y, Pan S, Jiang H, Zhang Y, Sun X (2012) Hydrogen sulfide protects cardiomyocytes from myocardial ischemia\u2013reperfusion injury by enhancing phosphorylation of apoptosis repressor with caspase recruitment domain. Tohoku J Exp Med 226:275\u2013285. \n                        https:\/\/doi.org\/10.1620\/tjem.226.275","journal-title":"Tohoku J Exp Med"},{"key":"664_CR67","doi-asserted-by":"publisher","first-page":"H1330","DOI":"10.1152\/ajpheart.00244.2008","volume":"295","author":"QC Yong","year":"2008","unstructured":"Yong QC, Lee SW, Foo CS, Neo KL, Chen X, Bian JS (2008) Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol Heart Circ Physiol 295:H1330\u2013H1340. \n                        https:\/\/doi.org\/10.1152\/ajpheart.00244.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"664_CR68","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/cb400090d","volume":"8","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Bhushan S, Yang CT, Otsuka H, Stein JD, Pacheco A, Peng B, Devarie-Baez NO, Aguilar HC, Lefer DJ, Xian M (2013) Controllable hydrogen sulfide donors and their activity against myocardial ischemia\u2013reperfusion injury. ACS Chem Biol 8:1283\u20131290. \n                        https:\/\/doi.org\/10.1021\/cb400090d","journal-title":"ACS Chem Biol"},{"key":"664_CR69","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1021\/acs.jmedchem.5b01033","volume":"58","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Yang CT, Organ C, Li Z, Bhushan S, Otsuka H, Pacheco A, Kang JM, Aguilar HC, Lefer DJ, Xian M (2015) Design, synthesis, and cardioprotective effects of n-mercapto-based hydrogen sulfide donors. J Med Chem 58:7501\u20137511. \n                        https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01033","journal-title":"J Med Chem"},{"key":"664_CR70","first-page":"17529","volume":"9","author":"XY Zhu","year":"2016","unstructured":"Zhu XY, Wang Y, Ding YL, Deng J, Yan XH (2016) Cardioprotection by H2S postconditioning engages the inhibition of endoplasmic reticulum stress. Int J Clin Exp Med 9:17529\u201317538","journal-title":"Int J Clin Exp Med"},{"key":"664_CR71","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1248\/bpb.32.1406","volume":"32","author":"Y Zhuo","year":"2009","unstructured":"Zhuo Y, Chen PF, Zhang AZ, Zhong H, Chen CQ, Zhu YZ (2009) Cardioprotective effect of hydrogen sulfide in ischemic reperfusion experimental rats and its influence on expression of survivin gene. Biol Pharm Bull 32:1406\u20131410. \n                        https:\/\/doi.org\/10.1248\/bpb.32.1406","journal-title":"Biol Pharm Bull"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00395-017-0664-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-017-0664-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-017-0664-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T12:26:00Z","timestamp":1515414360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00395-017-0664-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s00395-017-0664-8","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,14]]},"article-number":"6"}}